Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-10-27

Clinical Trial Update: Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial update describing a study of pharmacologically active constituents from chocolate and their potential symptomatic effects in patients with Park…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chocolate constituents (theobromine, caffeine, polyphenols)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Parkinson Disease | NA | Status: UNKNOWN